These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23962923)
1. CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders. Mattsson N; Insel P; Nosheny R; Zetterberg H; Trojanowski JQ; Shaw LM; Tosun D; Weiner M; Transl Psychiatry; 2013 Aug; 3(8):e293. PubMed ID: 23962923 [TBL] [Abstract][Full Text] [Related]
2. Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. Mattsson N; Insel PS; Donohue M; Jagust W; Sperling R; Aisen P; Weiner MW; JAMA Neurol; 2015 May; 72(5):554-60. PubMed ID: 25775167 [TBL] [Abstract][Full Text] [Related]
3. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies. van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267 [TBL] [Abstract][Full Text] [Related]
4. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus. Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S; Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
7. Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. Mattsson N; Insel P; Nosheny R; Trojanowski JQ; Shaw LM; Jack CR; Tosun D; Weiner M; Neurobiol Aging; 2014 Mar; 35(3):614-22. PubMed ID: 24094581 [TBL] [Abstract][Full Text] [Related]
8. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease. Adamczuk K; Schaeverbeke J; Vanderstichele HM; Lilja J; Nelissen N; Van Laere K; Dupont P; Hilven K; Poesen K; Vandenberghe R Alzheimers Res Ther; 2015 Dec; 7(1):75. PubMed ID: 26677842 [TBL] [Abstract][Full Text] [Related]